• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS2402399 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs(4) Generic Drug 2024-07-30 Shijiazhuang NO4 Pharmaceutical Co Ltd view
CYHS2302687 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs(4) Generic Drug 2023-10-11 Hunan Jiudian Pharmaceutical Co Ltd view
CYHS2300423 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs(4) Generic Drug 2023-02-09 Yichang Humanwell Pharmaceutical Co Ltd view
CYHS2300422 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs(4) Generic Drug 2023-02-09 Yichang Humanwell Pharmaceutical Co Ltd view
JYHB2200081 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs Supplementary Application 2022-02-15 view
JYHB2200082 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs Supplementary Application 2022-02-15 view
JYHB2101341 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs Supplementary Application 2021-08-19 view
JYHB2101340 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs Supplementary Application 2021-08-19 view
JYHB2001374 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs Supplementary Application 2020-08-21 辉瑞制药有限公司 Pfizer Pharmaceuticals Ltd Filed 2020-09-02 view
JYHB2001373 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs Supplementary Application 2020-08-21 辉瑞制药有限公司 Pfizer Pharmaceuticals Ltd Filed 2020-09-02 view
JYHB2001321 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs Supplementary Application 2020-08-21 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2020-12-30 view
JYHB2001320 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs Supplementary Application 2020-08-10 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2020-12-30 view
JYHB1801285 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs Supplementary Application 2018-11-12 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2018-12-05 view
JYHB1801286 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs Supplementary Application 2018-11-12 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2018-12-05 view
JYHZ1700230 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs License Renew 2018-01-19 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2018-03-28 view
JYHZ1700231 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs License Renew 2018-01-19 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2018-03-28 view
JYHB1700683 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs Supplementary Application 2017-05-13 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2017-07-18 view
JYHB1700682 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs Supplementary Application 2017-05-13 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2017-07-18 view
JYHB1400901 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs Supplementary Application 2014-07-04 Pfizer Italia s.r.l Pfizer Italia SRL Certificate Issued 2015-03-03 view
JYHB1400900 酒石酸托特罗定缓释胶囊 tolterodine tartrate Capsules, extended release Chemical Drugs Supplementary Application 2014-07-04 Pfizer Italia s.r.l Pfizer Italia SRL Certificate Issued 2015-03-03 view